# OnCo record m701 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/m701/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "m701" ;
  schema:name "M701"@en ;
  schema:description "M701 is Wuhan YZY Biopharma's EpCAM-CD3 bispecific antibody infused into the abdomen to control malignant ascites, in a phase 3 trial in China."@en ;
  schema:url <https://onco.cc/drugs/m701/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=M701> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific antibody (EpCAM x CD3), intraperitoneal" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/epcam/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/wuhan-yzy-biopharma/> ;
  onco:trials <https://onco.cc/trials/nct06432296/> .